Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Buprenorphine and naloxone
Medication labelBuprenorphine and naloxone sublingual tablets are indicated for maintenance treatment of opioid dependence. Buprenorphine and naloxone…
Why this: Advisory · dailymed-prescription
Buprenorphine and naloxone sublingual tablets are indicated for maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support.
- generic_name
- buprenorphine and naloxone
- product_names
- Buprenorphine and Naloxone
- ndc
- 60687-626, 60687-637, 42858-601, 60687-626-11, 60687-626-65, 42858-602, 60687-637-11, 60687-637-65
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en